Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bottomley

Showing results (271-280 of 290) with videos related to

Pageof 29
Sort By:
Radiology|November 1, 1984
Magnetic resonance imaging of pituitary lesions using 1.0 to 1.5 T field strengthL T Bilaniuk, R A Zimmerman, F W Wehrli, et al.
Magnetic Resonance in Medicine|February 4, 2021
Rapid, <math><msub><mi>B</mi><mn>1</mn></msub></math> -insensitive, dual-band quasi-adiabatic saturation transfer with optimal control for complete quantification of myocardial ATP fluxJack J Miller, Ladislav Valkovič, Matthew Kerr, et al.
Radiology|November 1, 1984
Cerebral magnetic resonance: comparison of high and low field strength imagingL T Bilaniuk, R A Zimmerman, F W Wehrli, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|August 9, 2020
Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapyJ Z Musoro, S C Sodergren, C Coens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2006
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975F Efficace, A Bottomley, E F Smit, et al.
Circulation|September 12, 2001
Attenuated myocardial vasodilator response in patients with hypertensive hypertrophy revealed by oxygenation-dependent magnetic resonance imagingG M Beache, D A Herzka, J L Boxerman, et al.
Journal of Geriatric Oncology|November 24, 2017
The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancerChantal Quinten, C Kenis, M Hamaker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2012
Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patientsD E Ediebah, C Coens, J T Maringwa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2022
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) creditS F Oosting, J Barriuso, A Bottomley, et al.
British Journal of Cancer|September 16, 2010
Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323)C M L van Herpen, M E Mauer, R Mesia, et al.
Pageof 29

Showing results (271-280 of 290) with videos related to

Sort By:
Pageof 29
Radiology|November 1, 1984
Magnetic resonance imaging of pituitary lesions using 1.0 to 1.5 T field strengthL T Bilaniuk, R A Zimmerman, F W Wehrli, et al.
Magnetic Resonance in Medicine|February 4, 2021
Rapid, <math><msub><mi>B</mi><mn>1</mn></msub></math> -insensitive, dual-band quasi-adiabatic saturation transfer with optimal control for complete quantification of myocardial ATP fluxJack J Miller, Ladislav Valkovič, Matthew Kerr, et al.
Radiology|November 1, 1984
Cerebral magnetic resonance: comparison of high and low field strength imagingL T Bilaniuk, R A Zimmerman, F W Wehrli, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|August 9, 2020
Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapyJ Z Musoro, S C Sodergren, C Coens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 14, 2006
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975F Efficace, A Bottomley, E F Smit, et al.
Circulation|September 12, 2001
Attenuated myocardial vasodilator response in patients with hypertensive hypertrophy revealed by oxygenation-dependent magnetic resonance imagingG M Beache, D A Herzka, J L Boxerman, et al.
Journal of Geriatric Oncology|November 24, 2017
The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancerChantal Quinten, C Kenis, M Hamaker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2012
Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patientsD E Ediebah, C Coens, J T Maringwa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2022
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) creditS F Oosting, J Barriuso, A Bottomley, et al.
British Journal of Cancer|September 16, 2010
Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323)C M L van Herpen, M E Mauer, R Mesia, et al.
Pageof 29